Treatment of Pre-term Neonates

This invention relates to the treatment of pre-term neonates with paraoxonase 3 (PON3) or serum amyloid A like protein 3 (SAA3) to reduce or prevent the morbidity and mortality associated with prematurity.

Patents:
WO 2,011,048,387

Inventor(s): SMITH GORDON [GB]; CHARNOCK-JONES DAVID STEPHEN [GB]

Type of Offer: Sale